With the very recent market approval of pitolisant (Wakix®), the interest in clinical applications of novel multifunctional histamine H3 receptor antagonists has clearly increased. Since histamine H3 receptor antagonists in clinical development have been tested for a variety of different indications, the combination of pharmacological properties in one molecule for improved pharmacological effects and reduced unwanted side-effects is rationally based on the increasing knowledge on the complex neurotransmitter regulations. The polypharmacological approaches on histamine H3 receptor antagonists on different G-protein coupled receptors, transporters, enzymes as well as on NO-signaling mechanism are described, supported with some lead structures.
Scheda prodotto non validato
Scheda prodotto in fase di analisi da parte dello staff di validazione
|Titolo:||Multiple Targeting Approaches on Histamine H3 Receptor Antagonists|
|Citazione:||Khanfar, M.A., Affini, A., Lutsenko, K., Nikolic, K., BUTINI, S., & Stark, H. (2016). Multiple Targeting Approaches on Histamine H3 Receptor Antagonists. FRONTIERS IN NEUROSCIENCE, 10, 201.|
|Appare nelle tipologie:||1.1 Articolo in rivista|